MicroRNA Market To Surpass USD 618.6 Million By 2027 At A CAGR Of 13.2%
The report analyzes and forecasts the MicroRNA Market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2022 to 2030. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global MicroRNA Market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the MicroRNA Market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of MicroRNA Market for the base year 2020 and the forecast between 2021 and 2028. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
Download Sample Report Copy From Here:https://www.acumenresearchandconsulting.com/request-sample/2545
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report. Primary research represents a bulk of research efforts, supplemented by extensive secondary research.
Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding. Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
Market Players as below:
The prominent players involved in global microRNA market are The Merck Group, Thermo Fisher Scientific, Inc., Horizon Discovery Group plc, Synlogic, QIAGEN, GeneCopoeia, Inc., New England Biolabs, Quantabio, NanoString Technologies, Inc., BioGenex, SeqMatic LLC., Miltenyi Biotec, and among others
The major market segments of MicroRNA Market are as below:
Market By Product
Instruments
Consumables
Market By Services
Sample Collection
Mirna cDNA Synthesis
Mirna Profiling & Purification
Next Generation Sequencing (Ngs)
Microarray
Real Time Pcr (Qrt-Pcr)
Others
Market By Application
Cardiovascular Diseases
Cancer
Neurological Diseases
Immunological Disorders
Infectious Diseases
Others
Market By End-User
Biotechnology & Pharmaceutical Companies
Academic & Government Research Institutes Others
Ask Query Here: richard@acumenresearchandconsulting.com or sales@acumenresearchandconsulting.com
Table Of Contents:
CHAPTER 1. Industry Overview of MicroRNA
1.1. Definition and Scope
1.1.1. Definition of MicroRNA
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global MicroRNA Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. MicroRNA Market By Product
1.2.3. MicroRNA Market By Services
1.2.4. MicroRNA Market By Application
1.2.5. MicroRNA Market By End-user
1.2.6. MicroRNA Market by Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Regulatory Compliance
3.6. Competitive Landscape, 2019
3.6.1. Player Positioning Analysis
3.6.2. Key Strategies Adopted By Leading Players
CHAPTER 4. MicroRNA Market By Product
4.1. Introduction
4.2. MicroRNA Revenue By Product
4.2.1. MicroRNA Revenue (US$ Mn) and Forecast, By Product, 2016-2027
4.2.2. Instruments
4.2.2.1. Instruments Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.3. Consumables
4.2.3.1. Consumables Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 5. MicroRNA Market Revenue By Services
5.1. Introduction
5.2. MicroRNA Revenue (US$ Mn) By Services
5.2.1. MicroRNA Revenue (US$ Mn) and Forecast By Services, 2016 – 2027
5.2.2. Sample Collection
5.2.2.1. Sample Collection Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3. MiRNA cDNA Synthesis
5.2.3.1. MiRNA cDNA Synthesis Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.4. MiRNA Profiling & Purification
5.2.4.1. MiRNA Profiling & Purification Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.5. Next Generation Sequencing (NGS)
5.2.5.1. Next Generation Sequencing (NGS) Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.6. Microarray
5.2.6.1. Next Microarray Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.7. Real Time PCR (qRT-PCR)
5.2.7.1. Real Time PCR (qRT-PCR) Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.8. Others
5.2.8.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 6. MicroRNA Market By Application
6.1. Introduction
6.2. MicroRNA Revenue (US$ Mn) By Application
6.2.1. MicroRNA Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
6.2.2. Cardiovascular Diseases
6.2.2.1. Cardiovascular Diseases Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3. Cancer
6.2.3.1. Cancer Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.4. Neurological Diseases
6.2.4.1. Neurological Diseases Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.5. Immunological Disorders
6.2.5.1. Immunological Disorders Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.6. Infectious Disease
6.2.6.1. Infectious Disease Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.7. Others
6.2.7.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 7. MicroRNA Market By End-user
7.1. Introduction
7.2. MicroRNA Revenue (US$) By End-user
7.2.1. MicroRNA Revenue (US$ Mn) and Forecast By End-user, 2016 – 2027
7.3. Biotechnology & Pharmaceutical Companies
7.3.1. Biotechnology & Pharmaceutical Companies Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.4. Academic & Government Research Institutes
7.4.1. Academic & Government Research Institutes Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.5. Others
7.5.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 8. North America MicroRNA Market By Country
8.1. North America MicroRNA Overview
8.2. U.S.
8.2.1. U.S. MicroRNA Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.2.2. U.S. MicroRNA Market Revenue (US$ Mn) and Forecast By Services, 2016-2027
8.2.3. U.S. MicroRNA Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.2.4. U.S. MicroRNA Market Revenue (US$ Mn) and Forecast By End-user, 2016-2027
8.3. Canada
8.3.1. Canada MicroRNA Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.3.2. Canada MicroRNA Market Revenue (US$ Mn) and Forecast By Services, 2016-2027
8.3.3. Canada MicroRNA Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.3.4. Canada MicroRNA Market Revenue (US$ Mn) and Forecast By End-user, 2016-2027
8.4. North America PEST Analysis
CHAPTER 9. Europe MicroRNA Market By Country
9.1. Europe MicroRNA Market Overview
9.2. U.K.
9.2.1. U.K. MicroRNA Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
9.2.2. U.K. MicroRNA Market Revenue (US$ Mn) and Forecast By Services, 2016-2027
9.2.3. U.K. MicroRNA Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
9.2.4. U.K. MicroRNA Market Revenue (US$ Mn) and Forecast By End-user, 2016-2027
9.3. Germany
9.3.1. Germany MicroRNA Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
9.3.2. Germany MicroRNA Market Revenue (US$ Mn) and Forecast By Services, 2016-2027
9.3.3. Germany MicroRNA Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
9.3.4. Germany MicroRNA Market Revenue (US$ Mn) and Forecast By End-user, 2016-2027
9.4. France
9.4.1. France MicroRNA Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
9.4.2. France MicroRNA Market Revenue (US$ Mn) and Forecast By Services, 2016-2027
9.4.3. France MicroRNA Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
9.4.4. France MicroRNA Market Revenue (US$ Mn) and Forecast By End-user, 2016-2027
9.5. Spain
9.5.1. Spain MicroRNA Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
9.5.2. Spain MicroRNA Market Revenue (US$ Mn) and Forecast By Services, 2016-2027
9.5.3. Spain MicroRNA Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
9.5.4. Spain MicroRNA Market Revenue (US$ Mn) and Forecast By End-user, 2016-2027
9.6. Rest of Europe
9.6.1. Rest of Europe MicroRNA Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
9.6.2. Rest of Europe MicroRNA Market Revenue (US$ Mn) and Forecast By Services, 2016-2027
9.6.3. Rest of Europe MicroRNA Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
9.6.4. Rest of Europe MicroRNA Market Revenue (US$ Mn) and Forecast By End-user, 2016-2027
9.7. Europe PEST Analysis
CHAPTER 10. Asia Pacific MicroRNA Market By Country
10.1. Asia Pacific MicroRNA Market Overview
10.2. China
10.2.1. China MicroRNA Market Revenue (US$ Mn) and Forecast By Product, 2016 – 2027
10.2.2. China MicroRNA Market Revenue (US$ Mn) and Forecast By Services, 2016 – 2027
10.2.3. China MicroRNA Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
10.2.4. China MicroRNA Market Revenue (US$ Mn) and Forecast By End-user, 2016 – 2027
10.3. Japan
10.3.1. Japan MicroRNA Market Revenue (US$ Mn) and Forecast By Product, 2016 – 2027
10.3.2. Japan MicroRNA Market Revenue (US$ Mn) and Forecast By Services, 2016 – 2027
10.3.3. Japan MicroRNA Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
10.3.4. Japan MicroRNA Market Revenue (US$ Mn) and Forecast By End-user, 2016 – 2027
10.4. India
10.4.1. India MicroRNA Market Revenue (US$ Mn) and Forecast By Product, 2016 – 2027
10.4.2. India MicroRNA Market Revenue (US$ Mn) and Forecast By Services, 2016 – 2027
10.4.3. India MicroRNA Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
10.4.4. India MicroRNA Market Revenue (US$ Mn) and Forecast By End-user, 2016 – 2027
10.5. Australia
10.5.1. Australia MicroRNA Market Revenue (US$ Mn) and Forecast By Product, 2016 – 2027
10.5.2. Australia MicroRNA Market Revenue (US$ Mn) and Forecast By Services, 2016 – 2027
10.5.3. Australia MicroRNA Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
10.5.4. Australia MicroRNA Market Revenue (US$ Mn) and Forecast By End-user, 2016 – 2027
10.6. South Korea
10.6.1. South Korea MicroRNA Market Revenue (US$ Mn) and Forecast By Product, 2016 – 2027
10.6.2. South Korea MicroRNA Market Revenue (US$ Mn) and Forecast By Services, 2016 – 2027
10.6.3. South Korea MicroRNA Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
10.6.4. South Korea MicroRNA Market Revenue (US$ Mn) and Forecast By End-user, 2016 – 2027
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific MicroRNA Market Revenue (US$ Mn) and Forecast By Product, 2016 – 2027
10.7.2. Rest of Asia-Pacific MicroRNA Market Revenue (US$ Mn) and Forecast By Services, 2016 – 2027
10.7.3. Rest of Asia-Pacific MicroRNA Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
10.7.4. Rest of Asia-Pacific MicroRNA Market Revenue (US$ Mn) and Forecast By End-user, 2016 – 2027
10.8. Asia Pacific PEST Analysis
CHAPTER 11. Latin America MicroRNA Market By Country
11.1. Latin America MicroRNA Market Overview
11.2. Brazil
11.2.1. Brazil MicroRNA Market Revenue (US$ Mn) and Forecast By Product, 2016 – 2027
11.2.2. Brazil MicroRNA Market Revenue (US$ Mn) and Forecast By Services, 2016 – 2027
11.2.3. Brazil MicroRNA Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
11.2.4. Brazil MicroRNA Market Revenue (US$ Mn) and Forecast By End-user, 2016 – 2027
11.3. Mexico
11.3.1. Mexico MicroRNA Market Revenue (US$ Mn) and Forecast By Product, 2016 – 2027
11.3.2. Mexico MicroRNA Market Revenue (US$ Mn) and Forecast By Services, 2016 – 2027
11.3.3. Mexico MicroRNA Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
11.3.4. Mexico MicroRNA Market Revenue (US$ Mn) and Forecast By End-user, 2016 – 2027
11.4. Rest of Latin America
11.4.1. Rest of Latin America MicroRNA Market Revenue (US$ Mn) and Forecast By Product, 2016 – 2027
11.4.2. Rest of Latin America MicroRNA Market Revenue (US$ Mn) and Forecast By Services, 2016 – 2027
11.4.3. Rest of Latin America MicroRNA Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
11.4.4. Rest of Latin America MicroRNA Market Revenue (US$ Mn) and Forecast By End-user, 2016 – 2027
11.5. Latin America PEST Analysis
CHAPTER 12. Middle East & Africa MicroRNA Market By Country
12.1. Middle East & Africa MicroRNA Market Overview
12.2. Saudi Arabia
12.2.1. Saudi Arabia MicroRNA Market Revenue (US$ Mn) and Forecast By Product, 2016 – 2027
12.2.2. Saudi Arabia MicroRNA Market Revenue (US$ Mn) and Forecast By Services, 2016 – 2027
12.2.3. Saudi Arabia MicroRNA Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
12.2.4. Saudi Arabia MicroRNA Market Revenue (US$ Mn) and Forecast By End-user, 2016 – 2027
12.3. UAE
12.3.1. UAE MicroRNA Market Revenue (US$ Mn) and Forecast By Product, 2016 – 2027
12.3.2. UAE MicroRNA Market Revenue (US$ Mn) and Forecast By Services, 2016 – 2027
12.3.3. UAE MicroRNA Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
12.3.4. UAE MicroRNA Market Revenue (US$ Mn) and Forecast By End-user, 2016 – 2027
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa MicroRNA Market Revenue (US$ Mn) and Forecast By Product, 2016 – 2027
12.4.2. Rest of Middle East & Africa MicroRNA Market Revenue (US$ Mn) and Forecast By Services, 2016 – 2027
12.4.3. Rest of Middle East & Africa MicroRNA Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
12.4.4. Rest of Middle East & Africa MicroRNA Market Revenue (US$ Mn) and Forecast By End-user, 2016 – 2027
12.5. Middle East & Africa PEST Analysis
CHAPTER 13. Player Analysis Of MicroRNA
13.1. MicroRNA Market Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global MicroRNA Market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14. Company Profile
14.1. The Merck Group
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (US$ Mn), 2019
14.1.3.2. The Merck Group 2019 MicroRNA Business Regional Distribution
14.1.4. Product/ Service and Specification
14.1.5. Recent Developments & Business Strategy
14.1.6. Manufacturing Plant Footprint Analysis
14.2. Thermo Fisher Scientific, Inc.
14.3. Horizon Discovery Group plc
14.4. Synlogic
14.5. QIAGEN
14.6. GeneCopoeia, Inc.
14.7. New England Biolabs
14.8. Quantabio
14.9. NanoString Technologies, Inc.
14.10. BioGene
14.11. SeqMatic LLC.
14.12. Miltenyi Biotec
14.13. Others
To Get Premium Report Full Copy in Form of Single user or Multiple user@https://www.acumenresearchandconsulting.com/buy-now/0/2545
About Us:
Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.
